Seagen  logo
Seagen SGEN

Quarterly report 2023-Q3
added 11-01-2023

report update icon

Seagen Cash Conversion Cycle 2011-2026 | SGEN

Annual Cash Conversion Cycle Seagen

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
219 155 107 373 119 271 391 410 379 277 734 -510

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
734 -510 244

Quarterly Cash Conversion Cycle Seagen

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
273 261 314 - 137 118 227 - 155 142 145 49.3 72.3 179 220 74.3 384 98.6 89.3 76.5 78.8 78.4 75 59.7 57.2 71.5 61.3 53.7 53.1 59.2 47.1 51.7 57.5 62.6 51.2 48.2 47.2 52.4 46 39.9 37.9 36.6 50.1 47.8 61.2 62.5 83.6 103 243 384 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
384 36.6 110

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer Cash Conversion Cycle Price % 24h Market Cap Country
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
46.6 $ 330.34 3.6 % $ 43.3 B usaUSA
CollPlant Biotechnologies Ltd. CollPlant Biotechnologies Ltd.
CLGN
130 $ 0.44 -16.64 % $ 5.04 M israelIsrael
I-Mab I-Mab
IMAB
-1.97 K - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
12.8 - - $ 40.3 B usaUSA
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
120 $ 24.98 1.17 % $ 3.05 B usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
82.8 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
17 - -1.52 % $ 24.7 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
294 $ 1.58 - $ 106 M usaUSA
Curis Curis
CRIS
103 $ 0.53 -3.07 % $ 6.98 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
117 - -24.86 % $ 820 K usaUSA
Crinetics Pharmaceuticals Crinetics Pharmaceuticals
CRNX
-4.27 K $ 37.7 1.26 % $ 3.55 B usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
1.1 K $ 49.15 -0.73 % $ 4.42 B schweizSchweiz
Advaxis Advaxis
ADXS
-143 K - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
-34.3 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
AIkido Pharma AIkido Pharma
AIKI
-1.92 - 1.93 % $ 17.4 M usaUSA
CytomX Therapeutics CytomX Therapeutics
CTMX
12.2 $ 4.4 -3.51 % $ 607 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
104 - - - russiaRussia
Cue Biopharma Cue Biopharma
CUE
43.1 $ 0.18 -1.61 % $ 17.1 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
154 - - $ 2.17 B usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
-172 $ 4.09 -0.97 % $ 437 M usaUSA
Cyclerion Therapeutics Cyclerion Therapeutics
CYCN
120 $ 4.15 -32.52 % $ 10.4 M usaUSA
Daré Bioscience Daré Bioscience
DARE
-1.64 K $ 1.81 4.02 % $ 20.2 M usaUSA
DBV Technologies S.A. DBV Technologies S.A.
DBVT
71.3 $ 20.36 -3.32 % $ 2.84 B franceFrance
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
21.2 $ 8.22 2.37 % $ 225 M israelIsrael
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
Denali Therapeutics Denali Therapeutics
DNLI
1.89 $ 19.38 -6.15 % $ 3.19 B usaUSA
Dyadic International Dyadic International
DYAI
-26.6 $ 0.87 -2.8 % $ 31.5 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
-58 - - $ 96.9 B britainBritain
Celldex Therapeutics Celldex Therapeutics
CLDX
-3.74 K $ 31.37 1.0 % $ 2.08 B usaUSA